Downregulation of circular RNA circ-HN1 suppressed the progression of gastric cancer through the miR-485-5p/GSK3A pathway

References

• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020 Aug 29;396(10251):635–648.
   PubMed Web of Science ®Google Scholar
• Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013 Mar;107(3):230–236.
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700–713.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhu Z, Shi Y. Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis. Bull Cancer. 2014 Jan 1;101(1):E1–12.
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017 Jul;39(7):1010428317714626.
   Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Cooper DA, Cortés-López M, Miura P. Genome-wide circRNA profiling from RNA-seq data. Methods Mol Biol. 2018;1724:27–41.
   PubMedGoogle Scholar
• Li R, Jiang J, Shi H, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020 May;77(9):1661–1680.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang Y, Yang J. Identification of potentially functional CircRNA-miRNA-mRNA regulatory network in gastric carcinoma using bioinformatics analysis. Med Sci Monit. 2019 Nov 20;25:8777–8796.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018 Feb 1;37(5):555–565.
   PubMed Web of Science ®Google Scholar
• Wang D, Jiang X, Liu Y, et al. Circular RNA circ_HN1 facilitates gastric cancer progression through modulation of the miR-302b-3p/ROCK2 axis. Mol Cell Biochem. 2021 Jan;476(1):199–212.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang M, Zang X, et al. CircHN1 affects cell proliferation and migration in gastric cancer. J Clin Lab Anal. 2020 Oct;34(10):e23433.
   PubMed Web of Science ®Google Scholar
• Sun D, Wang G, Xiao C, et al. Hsa_circ_001988 attenuates GC progression in vitro and in vivo via sponging miR-197-3p. J Cell Physiol. 2021 Jan;236(1):612–624.
   PubMed Web of Science ®Google Scholar
• Ma C, Wang X, Yang F, et al. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit. Mol Cancer. 2020 Nov 10;19(1):157.
   PubMed Web of Science ®Google Scholar
• Lu J, Wang YH, Yoon C, et al. Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis. Cancer Lett. 2020 Feb 28;471:38–48.
   PubMed Web of Science ®Google Scholar
• Ding L, Zhao Y, Dang S, et al. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4. Mol Cancer. 2019 Mar 28;18(1):45.
   PubMed Web of Science ®Google Scholar
• Zhang C, Xu B, Lu S, et al. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Mol Cancer. 2017 May 11;16(1):90.
   PubMedGoogle Scholar
• Pan Z, Fang Q, Li L, et al. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Cancer Lett. 2021 Mar 31;501:31–42.
   PubMed Web of Science ®Google Scholar
• Varisli L, Ozturk BE, Akyuz GK, et al. HN1 negatively influences the beta-catenin/E-cadherin interaction, and contributes to migration in prostate cells. J Cell Biochem. 2015 Jan;116(1):170–178.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Sun X, Mao QQ, et al. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met. Kaohsiung J Med Sci. 2020 Mar;36(3):196–205.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Gao F, Peng CG, et al. miR-485-5p promotes osteoporosis via targeting Osterix. Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4792–4799.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ponnusamy M, Liu C, et al. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy. Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2871–2881.
   PubMed Web of Science ®Google Scholar
• Chen Z, Li Q, Wang S, et al. miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2. Int J Mol Med. 2015 Oct;36(4):1136–1142. Epub 2015 Aug 3.
   PubMed Web of Science ®Google Scholar
• Lou C, Xiao M, Cheng S, et al. MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1alpha expression. Cell Death Dis. 2016 Mar 24;7(3):e2159.
   PubMedGoogle Scholar
• Zhang F, Li Q, Zhu K, et al. LncRNA LINC00265/miR-485-5p/IRF2-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells. Am J Transl Res. 2020 Jun 15;12(6):2451–2462.
   PubMed Web of Science ®Google Scholar
• Han DL, Wang LL, Zhang GF, et al. MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2809–2816.
   PubMed Web of Science ®Google Scholar
• Wang FR, Xu SH, Wang BM, et al. MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1. Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7197–7204.
   PubMed Web of Science ®Google Scholar
• Duan J, Zhang H, Li S, et al. The role of miR-485-5p/NUDT1 axis in gastric cancer. Cancer Cell Int. 2017 Oct 17;17:92.
   PubMed Web of Science ®Google Scholar
• Kang M, Ren MP, Zhao L, et al. miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1. Am J Transl Res. 2015 Nov 15;7(11):2212–2222.
   PubMed Web of Science ®Google Scholar
• Jing LL, Mo XM. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer. Eur Rev Med Pharmacol Sci. 2016 Apr;20(8):1516–1520.
   PubMed Web of Science ®Google Scholar
• De Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ Action through miRNA Editing. Int J Mol Sci. 2019 Dec 11;20(24):6249.
   PubMed Web of Science ®Google Scholar
• Ocasio JK, Bates RDP, Rapp CD, et al. GSK-3 modulates SHH-driven proliferation in postnatal cerebellar neurogenesis and medulloblastoma. Development. 2019 Oct 10;146(20):dev177550.
   PubMed Web of Science ®Google Scholar
• Liu S, Fan W, Gao X, et al. Estrogen receptor alpha regulates the Wnt/beta-catenin signaling pathway in colon cancer by targeting the NOD-like receptors. Cell Signal. 2019 Sep;61:86–92.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018 Jan;62:50–60.
   PubMed Web of Science ®Google Scholar
• Yue Z, Li HT, Yang Y, et al. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information. Oncotarget. 2016 Jun 14;7(24):36092–36100.
   PubMedGoogle Scholar
• Böhrnsen F, Godek F, Kiesel J, et al. Influence of TGF-beta1 on tumor transition in oral cancer cell and BMSC co-cultures. J Craniomaxillofac Surg. 2017 May;45(5):731–740.
   PubMed Web of Science ®Google Scholar
• Hou P, Wu C, Wang Y, et al. A genome-wide CRISPR screen identifies genes critical for resistance to FLT3 inhibitor AC220. Cancer Res. 2017 Aug 15;77(16):4402–4413.
   PubMed Web of Science ®Google Scholar